These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 981924)

  • 1. [Fate of patients having ankylosing spondylarthritis in a military environment. (apropos of 132 cases)].
    Doury P; Pattin S; Ribot C; Lathuillière B; Chaouat D
    Rev Rhum Mal Osteoartic; 1976; 43(Suppl 2):10-2. PubMed ID: 981924
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of active ankylosing spondylitis with pamidronate.
    Haibel H; Brandt J; Rudwaleit M; Soerensen H; Sieper J; Braun J
    Rheumatology (Oxford); 2003 Aug; 42(8):1018-20. PubMed ID: 12869678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Feldene (piroxicam) in the treatment of ankylosing spondylitis].
    Sadowska-Wróblewska M; Garwolińska H; Radzikowska B
    Reumatologia; 1983; 21(1):55-8. PubMed ID: 6359311
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
    Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
    Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of ankylosing spondylitis with acemetacin, a new non-steroidal antirheumatic agent].
    Peter E; Hartl PW
    Med Welt; 1982 Nov; 33(45):1600-6. PubMed ID: 7176885
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some observations on therapy efficacy in a sample of 111 patients suffering from ankylosing spondylarthritis, assisted in the Clinic of Rheumatology and Rehabilitation Iaşi].
    Tigău MM; Rezuş E; Manole A; Matei M; Trifan M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):716-20. PubMed ID: 20191821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial.
    Sydnes OA
    Br J Clin Pract; 1981 Jan; 35(1):40-4. PubMed ID: 7020732
    [No Abstract]   [Full Text] [Related]  

  • 8. [Continuing training of patients with advanced ankylosing spondylitis].
    Hørslev-Petersen K; Rasmussen JO; Helin P
    Ugeskr Laeger; 1985 Jan; 147(2):99-101. PubMed ID: 3969741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Sadkiewicz S; Barwik-Schramm A; Grzywa M; Letkiewicz C; Piotrowska E; Procel Z; Reszkowska H; Wippel A; Woźniak M; Zmudzińska I
    Reumatologia; 1982; 20(1-2):75-80. PubMed ID: 6761815
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of benoxaprofen and indomethacin in ankylosing spondylitis.
    Bird HA; Rhind VM; Pickup ME; Wright V
    J Rheumatol Suppl; 1980; 6():139-42. PubMed ID: 6993670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.
    Cairns AP; Wright SA; Taggart AJ; Coward SM; Wright GD
    Ann Rheum Dis; 2005 Feb; 64(2):338-9. PubMed ID: 15096328
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ankylosing spondylarthritis. Current etiological concepts. Medico-military deductions].
    Doury P; Dechelotte J; Pattin S; Durosoir JL
    Ann Med Interne (Paris); 1972 May; 123(5):533-40. PubMed ID: 5081517
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
    Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ankylosing spondylitis. Comparative trial of two non-steroidal anti-inflammatory agents: pirprofen and ketoprofen].
    Renier JC; Fournier M; Loyau G; Roux H
    Nouv Presse Med; 1982 Aug; 11(33):2494-6. PubMed ID: 6752874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic evolutive polyarthritis and ankylopoietic spondylarthritis. National survey].
    López Prats JL
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):20-30. PubMed ID: 5997982
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.
    Smith MD; Gibson RA; Brooks PM
    J Rheumatol; 1985 Apr; 12(2):299-305. PubMed ID: 4032403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of solasodin in the treatment of some internal diseases].
    Milimovka ME; Konovalov MN; Boĭdykh RI; Kazakov MG; Rybnikov NI; Strizhevskaia AZ
    Vrach Delo; 1966 May; 5():62-5. PubMed ID: 5995513
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of intestinal permeability in ankylosing spondylarthritis with a test using Cr-EDTA].
    Wendling D; Bidet A; Guidet M
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):29-32. PubMed ID: 2108485
    [No Abstract]   [Full Text] [Related]  

  • 19. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of ankylosing spondylitis].
    Louyot P; Mougin G; Legras B; Montet Y; Combebias JF; Pourel J; Simon JM; Diebold P
    Rev Rhum Mal Osteoartic; 1970 Apr; 37(4):281-307. PubMed ID: 5421589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.